← Leaderboards
Sophia M Orbach
University Of Michigan At Ann Arbor
$194,098
Attributed
$194,098
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $68.6K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$194,098 · 1
By mechanism
F32$194,098 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Weiping Zou$38,970,401
- Celina G Kleer$13,464,529
- Arul M Chinnaiyan$35,112,976
- Brian D. Ross$27,286,369
- Theodore S Lawrence$30,022,406
Others in their field
Other Emerging Leaders on “Female”
- Greg Yothers · University Of Chicago$35,003,821
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,407,352
- Nadine Georges Rouphael · Emory University$13,654,706
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
FemaleBehaviorBaseAdultCancer Stem CellCancer TypeCellsBiocompatible MaterialsBreastClinical DiagnosticsClinical ResearchDetectionDiagnosisDiagnosticDisease ProgressionDistalDistant MetastasisEarly DiagnosisEffective TherapyChemotherapyElementsEnvironmentEvolutionFoundations
Grant awards (3)
Heterogeneity of the Early Metastatic Niche in Cancer Progression and Chemoresistance$68,562
F32 · FY2021 · CA · contact PI
Heterogeneity of the Early Metastatic Niche in Cancer Progression and Chemoresistance$64,310
F32 · FY2020 · CA · contact PI
Heterogeneity of the Early Metastatic Niche in Cancer Progression and Chemoresistance$61,226
F32 · FY2019 · CA · contact PI